These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 35380389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. US rheumatologists' beliefs and knowledge about biosimilars: a survey.
    Gibofsky A, McCabe D.
    Rheumatology (Oxford); 2021 Feb 01; 60(2):896-901. PubMed ID: 33146388
    [Abstract] [Full Text] [Related]

  • 3. Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.
    Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J, Velten M, CRI (Club “Rhumatismes et Inflammations”).
    BioDrugs; 2016 Dec 01; 30(6):585-592. PubMed ID: 27848166
    [Abstract] [Full Text] [Related]

  • 4. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians.
    Cohen H, Beydoun D, Chien D, Lessor T, McCabe D, Muenzberg M, Popovian R, Uy J.
    Adv Ther; 2017 Jan 01; 33(12):2160-2172. PubMed ID: 27798772
    [Abstract] [Full Text] [Related]

  • 5. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.
    van Overbeeke E, De Beleyr B, de Hoon J, Westhovens R, Huys I.
    BioDrugs; 2017 Oct 01; 31(5):447-459. PubMed ID: 28929342
    [Abstract] [Full Text] [Related]

  • 6. Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States.
    Teeple A, Ellis LA, Huff L, Reynolds C, Ginsburg S, Howard L, Walls D, Curtis JR.
    Curr Med Res Opin; 2019 Apr 01; 35(4):611-617. PubMed ID: 30712393
    [Abstract] [Full Text] [Related]

  • 7. Medical specialists' attitudes to prescribing biosimilars.
    Hemmington A, Dalbeth N, Jarrett P, Fraser AG, Broom R, Browett P, Petrie KJ.
    Pharmacoepidemiol Drug Saf; 2017 May 01; 26(5):570-577. PubMed ID: 28233367
    [Abstract] [Full Text] [Related]

  • 8. Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey.
    Kolbe AR, Kearsley A, Merchant L, Temkin E, Patel A, Xu J, Jessup A.
    BioDrugs; 2021 May 01; 35(3):363-372. PubMed ID: 33826078
    [Abstract] [Full Text] [Related]

  • 9. Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey.
    Marín-Jiménez I, Carrascosa JM, Guigini MA, Monte-Boquet E.
    Farm Hosp; 2021 Jul 07; 45(5):240-246. PubMed ID: 34806583
    [Abstract] [Full Text] [Related]

  • 10. Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey.
    Chapman SR, Fitzpatrick RW, Aladul MI.
    BMJ Open; 2017 Jun 21; 7(6):e016730. PubMed ID: 28637743
    [Abstract] [Full Text] [Related]

  • 11. Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide survey.
    Frantzen L, Cohen JD, Tropé S, Beck M, Munos A, Sittler MA, Diebolt R, Metzler I, Sordet C.
    Joint Bone Spine; 2019 Jul 21; 86(4):491-496. PubMed ID: 30659920
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Physicians' Knowledge and Attitudes Towards Biosimilars in Russia and Issues Associated with Their Prescribing.
    Karateev D, Belokoneva N.
    Biomolecules; 2019 Feb 11; 9(2):. PubMed ID: 30754705
    [Abstract] [Full Text] [Related]

  • 13. Patients' Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey.
    Aladul MI, Fitzpatrick RW, Chapman SR.
    BioDrugs; 2017 Oct 11; 31(5):439-446. PubMed ID: 28752242
    [Abstract] [Full Text] [Related]

  • 14. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
    O'Callaghan J, Bermingham M, Leonard M, Hallinan F, Morris JM, Moore U, Griffin BT.
    Regul Toxicol Pharmacol; 2017 Aug 11; 88():252-261. PubMed ID: 28666961
    [Abstract] [Full Text] [Related]

  • 15. Changes in Biosimilar Knowledge among European Crohn's Colitis Organization [ECCO] Members: An Updated Survey.
    Danese S, Fiorino G, Michetti P.
    J Crohns Colitis; 2016 Nov 11; 10(11):1362-1365. PubMed ID: 27112706
    [Abstract] [Full Text] [Related]

  • 16. Attitudes towards subsequent entry biologics/biosimilars: A survey of Canadian rheumatologists.
    Grabowski D, Henderson B, Lam D, Keystone EC, Thorne C, Jamal S, Pope J, Haraoui B, Lin D, Revers L.
    Clin Rheumatol; 2015 Aug 11; 34(8):1427-33. PubMed ID: 25586522
    [Abstract] [Full Text] [Related]

  • 17. Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany.
    Sullivan E, Piercy J, Waller J, Black CM, Kachroo S.
    PLoS One; 2017 Aug 11; 12(4):e0175826. PubMed ID: 28410403
    [Abstract] [Full Text] [Related]

  • 18. Biosimilars for Pediatric Patients With Inflammatory Bowel Disease: Pediatric Gastroenterology Clinical Practice Survey.
    Maltz RM, McClinchie MG, Boyle BM, McNicol M, Morris GA, Crawford EC, Moses J, Kim SC.
    J Pediatr Gastroenterol Nutr; 2023 May 01; 76(5):616-621. PubMed ID: 36827968
    [Abstract] [Full Text] [Related]

  • 19. Provider and patient knowledge gaps on biosimilars: insights from surveys.
    Gibofsky A, Evans C, Strand V.
    Am J Manag Care; 2022 Nov 01; 28(12 Suppl):S227-S233. PubMed ID: 36493396
    [Abstract] [Full Text] [Related]

  • 20. Physicians' perceptions of the uptake of biosimilars: a systematic review.
    Sarnola K, Merikoski M, Jyrkkä J, Hämeen-Anttila K.
    BMJ Open; 2020 May 05; 10(5):e034183. PubMed ID: 32371511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.